Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 201–250 of 1,372 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05595109	Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients	unknown	Phase 2 / Phase 3	56	Tanta UniversityOTHER	1	Oct 26, 2022	clinicaltrials
NCT02773485	Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma	unknown	Phase 3	155	Tata Memorial HospitalOTHER_GOV	1	Oct 21, 2022	clinicaltrials